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Abstract
Background: Background: Cytolethal distending toxin (CDT) is one of the well-characterized
virulence factors of Campylobacter jejuni, but it is unknown how CDT becomes surface-exposed or
is released from the bacterium to the surrounding environment.
Results: Our data suggest that CDT is secreted to the bacterial culture supernatant via outer
membrane vesicles (OMVs) released from the bacteria. All three subunits (the CdtA, CdtB, and
CdtC proteins) were detected by immunogold labeling and electron microscopy of OMVs.
Subcellular fractionation of the bacteria indicated that, apart from the majority of CDT detected in
the cytoplasmic compartment, appreciable amounts (20-50%) of the cellular pool of CDT proteins
were present in the periplasmic compartment. In the bacterial culture supernatant, we found that
a majority of the extracellular CDT was tightly associated with the OMVs. Isolated OMVs could
exert the cell distending effects typical of CDT on a human intestinal cell line, indicating that CDT
is present there in a biologically active form.
Conclusion:  Our results strongly suggest that the release of outer membrane vesicles is
functioning as a route of C. jejuni to deliver all the subunits of CDT toxin (CdtA, CdtB, and CdtC)
to the surrounding environment, including infected host tissue.
Background
Campylobacter jejuni is recognized as the most frequently
isolated bacterial cause of food-borne gastroenteritis
worldwide. It is found in both developed and developing
parts of the world [1,2]. Clinical illness ranges from mild
self-limiting, non-inflammatory diarrhea to severe
inflammatory bloody diarrhoea that may be associated
with pyrexia and bacteriaemia [1]. In addition, Campylo-
bacter enteritis has been associated with subsequent devel-
opment of Guillain Barré syndrome, an acute
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inflammatory polyneuropathy [3]. Although various viru-
lence factors such as adherence and invasive abilities and
toxin production and motility have been implicated [4-8],
the precise mechanism(s) involved in the pathogenesis is
yet to be elucidated. The pathogenesis of C. jejuni is poorly
understood, partly because of the lack of a suitable animal
model and partly due to the difficulties in genetic manip-
ulation [9]. Bacterial toxins have been considered impor-
tant factors for the pathogenesis of Campylobacter
infection. The best characterized toxin of Campylobacter
spp. is the cytolethal distending toxin (CDT). The C. jejuni
cdt operon consists of three adjacent genes, cdtA, cdtB and
cdtC, that encode proteins with predicted molecular
masses of 27, 29 and 20 kDa, respectively [10]. The effect
of CDT was first described as an activity in culture super-
natants of Campylobacter spp. and of certain enteropatho-
genic strains of Escherichia coli that caused eukaryotic cells
to slowly distend over a period of 2-5 days, eventually
leading to cell death [11]. CDT appears to be common in
C. jejuni strains e.g. in one study of 117 isolates there was
positive evidence for CDT in 114 of the isolates in Vero
cell assays [12]. A study in Bahrain showed that among
the 96 C. jejuni strains examined, 80 (83.0%) were cdtB
positive and 16 (17.0%) were negative by PCR [13].
Recently, Jain et al described that the presence of the cdtB
gene in C. jejuni was associated with increased adherence
to, invasion of and cytotoxicity towards HeLa cells [14].
The significant pathological changes in the colons of mice
treated with the supernatant containing C. jejuni CDT sug-
gested that CDT is an important virulence attribute and
that the colon is the major target of CDT.
CDT belongs to a family of bacterial protein toxins that
affects the epithelial cell layer and interrupts the cell divi-
sion process with resulting cell cycle arrest and cell death
[10,15]. CDT activity is not unique to E. coli and Campylo-
bacter spp. but has been described in various other Gram-
negative bacteria including Shigella  spp.,  Helicobacter
hepaticus,  Haemophilus ducreyi, and Actinobacillus actino-
mycetemcomitans. [16]. It has been suggested that CDT is a
tripartite "AB2" toxin in which CdtB is the active toxic
unit; CdtA and CdtC make up the "B2" units required for
CDT binding to target cells and for delivery of CdtB into
the cell interior [17]. The primary effect of the CDTs,
regardless of their bacterial origin, is eukaryotic cell cycle
arrest at the G2/M stage with resultant cessation of cell
division due to the DNase activity of the CdtB subunit
[4,17,18].
Interestingly, in the case of Salmonella typhi, that is lacking
the genes for CdtA and CdtC, the CdtB protein was deliv-
ered into the target cell upon entry of this invasive bacte-
rium [19]. It was proposed that S. typhi synthesizes and
secretes CdtB once it has reached an intracellular compart-
ment of the host cell where the toxin can be either retro-
translocated to the cytosol or transported to a
compartment where retrotranslocation can take place.
Three subunits of CDT appear to be constitutively synthe-
sized, assembled into a CDT complex and translocated
into the periplasm in bacterial cells [20] The CDT complex
is then secreted into the culture supernatant, probably via
CdtA that undergoes post-translational cleavage at its N-
terminal signal sequence [20,21]. It has been shown that
a proper complex of CdtA, CdtB and CdtC and its binding
to the host cell are required for maximal cytotoxic activity
[22]. In case of CDT from Actinobacillus actinomycetemcom-
itans, upon binding of the holotoxin to the target cells,
CdtB is internalized whereas CdtA and CdtC likely remain
associated with the membrane [23]. In S. typhimurium it
was described that the CdtB protein has a Sec-dependent
secretion signal sequence at the amino terminal end that
is cleaved during translocation of the protein across the
cytoplasmic membrane into the periplasmic space where
CdtB undergoes folding and assembly to form the mature
protein. A S. typhi mutant lacking the Sec-dependent sig-
nal sequence for CdtB was not cytotoxic [19]. However, it
has remained unclear how CDT becomes surface-exposed
and released from the different bacterial cells.
In general, proteins have to reach their final destination to
exhibit their physiological functions. Outer membrane
vesicles (OMVs) are common to a wide variety of Gram-
negative bacteria and are produced during the course of
normal metabolism and cell growth. As OMVs are blebs
from the outer membrane, the outer membrane associ-
ated protein(s) as well as some periplasmic components
are released in association with OMVs. Once the OMVs
are free from the bacterium, they appear as small mem-
brane vessels including periplasmic constituents and
outer membrane components. The role of OMVs is likely
multifaceted: OMVs may act as delivery vehicles for bacte-
rial toxins lacking typical signal sequences [24-28], pro-
mote cell-cell communication via transit of signalling
molecules [29], and can inhibit phagosome-lysosome
fusion during macrophage infection [30]. OMVs are
potentially rich in antigens that serve as initial targets for
innate and adaptive immune recognition [31], generating
protective immunity against bacterial challenge when
used as an immunogen [32]. Ricci et al. found that a por-
tion of secreted VacA toxin from H. pylori was OMV-asso-
ciated and that the OMV-associated VacA caused a
statistically significant vacuolation of gastric epithelial
cells [33]. They therefore suggested that OMVs may repre-
sent an important vehicle for delivering virulence factors
to the gastric mucosa and that OMV-associated VacA
could play a pathobiological role different from that of
free and soluble toxin. There is no detailed study of OMVs
from C. jejuni. Here we report that biologically active CDT
is secreted from C. jejuni bacterial cells in association with
OMVs.BMC Microbiology 2009, 9:220 http://www.biomedcentral.com/1471-2180/9/220
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Methods
Bacterial strains and culture conditions
C. jejuni strain 81-176 [34,35] and its mutant derivative
DS104 cdtA::km [20] were used in our experiments. C.
jejuni strains were grown on Mueller-Hinton agar plates
supplemented with kanamycin (Km 25 g/ml) when
needed, under microaerobic conditions at 42°C.
Cell line media and culture conditions
The human ileocecum carcinoma cell line HCT8 (ATCC
number CCL-224) was kindly provided by the Institute
for Molecular Infection Biology, University of Würzburg.
HCT8 cells were cultured in RPMI 1640 (Gibco) supple-
mented with 2 mM glutamine, 1 mM pyruvate, 10% FCS
and 50 g/ml gentamicin. The cells were cultivated at
37°C in a 5% CO2 atmosphere.
Isolation of outer membrane vesicles
OMVs were isolated from culture fluid as previous
described [25] with some modifications. Briefly, bacteria
were inoculated in a 600 ml tissue culture flask containing
Muller-Hinton agar and 100 ml of Muller-Hinton broth
(biphasic media) and incubated under microaerobic con-
ditions for 24 h. Bacterial cells were removed from culture
fluid by centrifugation at 5000 × g for 30 min. The super-
natants were filtered through a 0,45 m-pore-size mem-
brane filter (Sartorius). The cell-free supernatants were
centrifuged at 100 000 × g for 2 h at 4°C in a 45 Ti rotor
(Beckman Instruments Inc.) to pellet the vesicles. The ves-
icles were suspended in 20 mM Tris-HCl (pH 8.0) or 50
mM HEPES. The proteins in the supernatants collected
before and after OMV isolation, respectively, were concen-
trated by trichloroacetic acid precipitation.
Atomic force microscopy
Ten l of the vesicle samples were placed onto freshly
cleaved mica (Goodfellow Cambridge Ltd., Cambridge,
United Kingdom). The samples were blot dried and desic-
cated prior to imaging. Imaging was done on a Nanoscope
IIIa (Digital Instruments, Santa Barbara) Atomic Force
Microscope using Tapping ModeTM. A silicon probe was
oscillated at its resonant frequency of approximately 300
kHz, selected by the Nanoscope software. Images were
collected in air at a scan rate of 0.8-1.5 Hz, depending on
scan size and sample number (512 or 256 samples/
image). The final images were plane fitted in both axes
and presented in a surface plot of the height mode.
Cell fractionation
For the whole cell lysate fractions, the bacteria (100 l)
from the cultures were centrifuged at 12,000 × g for 5 min
and 5 l bacterial suspensions were loaded in the well.
The bacteria (1 ml samples from cultures with a cell den-
sity of ca 5 × 109/ml) were harvested by centrifugation and
washed twice in a 0.2 volume of ice-cold 0.01 M Tris-HCl
(pH 8.0), 0.3 M NaCl before being resuspended in 0.2 ml
of 0.03 M Tris-HCl (pH 8.0), 20% (wt/vol) sucrose, and
0.1 mM EDTA at 25°C. After 10 min the cells were pel-
leted and rapidly suspended in 0.3 ml of ice-cold 0.5 mM
MgCl2. After incubation on ice for 10 min, the cells were
removed by centrifugation at 12,000 × g. The supernatant
was used as the periplasmic protein extract. The cell pellet
was then disrupted by sonication in 0.5 ml ice-cold water.
The cell debris and unbroken cells were removed by cen-
trifugation at 5,000 × g for 10 min at 4°C, and the next
supernatant was fractionated into the membrane and
cytoplasmic fractions by centrifugation at 10,000 × g for
30 min at 4°C. The resulting supernatant was used as a
cytoplasmic fraction. The sediment was resuspended in
sterile distilled water and used as the membrane fraction.
In order to separate the inner and outer membranes, the
membrane fraction was further treated with N-lauryl sarc-
osyl at a final concentration of 2% at room temperature
and then centrifuged at 15,000 × g for 30 min. The result-
ing sediment was used as the outer membrane fraction,
and the supernatant was used as the inner membrane frac-
tion after dialysis and precipitation. Extracellular, peri-
plasmic, cytoplasmic, and membrane-bound proteins
were concentrated by precipitation with ice-cold trichlo-
roacetic acid (final concentration, 10%). The precipitated
proteins were collected by centrifugation at 12,000 × g,
washed with acetone, dried under vacuum, and dissolved
in sample buffer (50 mM Tris-HCl [pH 6.8], 10% glycerol,
5%  -mercaptoethanol, 2% sodium dodecyl sulfate
[SDS], 0.05% bromophenol blue). Samples were neutral-
ized by addition of a saturated Tris solution and boiled for
5 min at 100°C before SDS-PAGE analysis. The amount of
sample from each extract used for the SDS-PAGE was as
follows: 2.5 l of the 150 l cytoplasmic (C) extract; 2.5 l
of the 40 l inner membrane (IM) extract; 5 l of the 100
l periplasmic (P) extract; 2.5 l of the 40 l outer mem-
brane (OM) extract and 2.5 l of the 300 l whole cell
(WC) extract. In all cases the extracts were derived from 1
ml culture samples and the relative amount of the extracts
used for SDS-PAGE in comparison with the amount of
WC extract used (arbitrarily set to 1.0) were 2 × for C; 8 ×
for IM; 6 × for P, and 8 × for OM.
SDS-PAGE and N-terminal sequencing
SDS-PAGE was performed using the method described by
Laemmli [36]. Proteins were blotted onto PVDF mem-
brane and stained with Coomassie brilliant blue. 50%
methanol was used for de-staining the membrane to visu-
alize the protein bands. Proteins present in visible bands
were excised from the membrane for N-terminal sequenc-
ing. Determination of the N-terminal amino acid
sequence of proteins was achieved by automated Edman
degradations of samples blotted onto PVDF membranes.
The sequencing was performed on a Procise 494
Sequencer (Applied Biosystems) with an on-line PTH-BMC Microbiology 2009, 9:220 http://www.biomedcentral.com/1471-2180/9/220
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analyzer. A sufficient number of residues were determined
to allow unambiguous identification (100% identity;
using the NCBI BLAST database). PageRuler Prestained
Protein Ladder #SM0671 marker (Fermentas) and low
range molecular weight markers RPN 755 (Amersham
Biosciences) were used as molecular weight markers of
proteins and LPS in the SDS-PAGE silver stained gels.
Western immunoblot analysis
The isolated vesicles and the different sub-cellular extracts
(see below) were subjected to polyacrylamide gel electro-
phoresis and then blotted onto a PVDF membrane. Pro-
teins were identified using different primary polyclonal
antisera at a final dilution of 1:5000 against CdtA, CdtB,
CdtC [20], an anti-Omp50 antiserum at a final dilution of
1:5000 [37], an anti-HtrA (E. coli) antiserum at a final
dilution of 1:7500 [38], and anti-CRP antiserum at a final
dilution of 1:3000 [39]. For CRP detection, we used E. coli
anti-CRP antiserum since the CRP proteins from C. jejuni
and E. coli have 80% identity at protein level. Anti-rabbit
horseradish peroxidase-conjugate was used as a secondary
antiserum at a final dilution of 1:20,000. The ECL+ chemi-
luminescence system was used to detect the level of
chemiluminescence that was then monitored using a
Flour-S MultiImager (BioRad) and by autoradiography.
Lipooligosaccharide analysis and staining
Lipooligosaccharide (LOS) samples were prepared from
whole-cell lysates (0.1 ml samples) and OMVs (50 l sam-
ples of the OMV preparations). The samples were sub-
jected to complete digestion with proteinase K as
described earlier [40]. The isolated LOS samples (2.5 l of
the whole cell extracts and 10 l of the OMV extracts,
respectively) were separated on 16% Tricine gels (Invitro-
gen, Carlsbad, CA, USA) and then silver stained [41].
Dissociation assay
Vesicle samples (60 g/ml total protein) in 50 mM HEPES
(pH 7.3) were incubated on ice for 1 hour in the absence
or presence of either NaCl (1 M), Na2CO3 (0.1 M) pH
10.0, Urea (8 M) or 1% SDS [28]. Samples were then cen-
trifuged at 100,000 × g for 2 hours at 4°C and both pellet
and supernatant fractions were analyzed by SDS-PAGE
and immunoblot analyses using anti-CdtA, anti-CdtB,
anti-CdtC polyclonal antiserum and anti-GroEL polyclo-
nal antiserum against E. coli GroEL protein. Before load-
ing, the soluble proteins in the supernatant were
concentrated by TCA-precipitation.
Electron microscopy and immunogold labeling
Samples from vesicle preparations were negatively stained
with a solution of 0.1% uranyl acetate on carbon coated
Formvar grids and examined under the electron micro-
scope. Micrographs were taken with a JEOL 2000EX elec-
tron microscope (JEOL Co., Ltd., Akishima, Japan)
operated at an accelerating voltage of 100 kV.
For immunoelectron microscopy, a colloidal gold probe
(Wako Pure Chemical Industries Ltd., Osaka, Japan) was
used to label the specific reaction sites of anti-CDT sera in
the specimens of OMVs from C. jejuni. To label the speci-
mens, a 50 l sample (ca 3 g protein) of the OMV prep-
aration was treated with antiserum appropriately diluted
in phosphate-buffered saline (PBS) for 30 min at 37°C.
The OMVs then were separated from the serum by centrif-
ugation at 100,000 × g for 2 h at 4°C. After being washed
three times with PBS, the OMV samples were mixed with
a suspension of the colloidal gold probe, and the mixture
was kept at room temperature for 30 min. After being
washed with PBS to remove unbound gold particles, the
OMV samples were negatively stained with 0.1% uranyl
acetate on carbon coated Formvar grids and examined
under the electron microscope.
Cytolethal distending assays with HCT8 cells
HCT8 cells were seeded in 24-well plates (Falcon) and
grown to 50% confluence. 50 l of vesicle samples (ca 3
g protein) were added to the cells. The occurrence of
cytotoxic effects was monitored for up to 72 h. Cells were
fixed with 2% paraformaldehyde in PBS pH 7.3 for 10
min. After fixation, cells were washed twice with PBS and
incubated with 0.1 M glycine for 5 min at room tempera-
ture. After washing twice with PBS, the cells were permea-
bilized with 0.5% Triton X-100 (Sigma-Aldrich). Actin
was stained with Alexa Fluor 488 phalloidin (Molecular
probes, Invitrogen, Oregon, USA) containing 1% BSA
(Sigma-Aldrich). After thorough washing with PBS, the
nuclei were stained with DAPI (Sigma-Aldrich) (1:5,000)
for 5 min before mounting in Mowiol (Scharlau Chemie
S. A.) containing antifade (P-phenylene diamine). Cells
were analysed using a Zeiss Axioskop routine microscope
and photographed with a Hamamatsu digital camera.
Thymidine incorporation analysis
DNA synthesis was assessed by measuring [3H] thymidine
incorporation in HCT8 cells. Cells were seeded in 96-well
plates and grown to 25% confluence. After 48 h of incu-
bation with 10 l of OMVs (0.6 g protein) from strains
81-176 and its cdtA::km mutant, [3H] thymidine (0.5 Ci/
well; Amersham) was added and the incubation was con-
tinued for another 4 h. Cells were harvested with a SKA-
TRON semiautomatic cell harvester and [3H] thymidine
uptake was determined with a Beta Counter (LKB Wallace
1218 Rackbeta liquid scintillation counter).
Results and discussion
Analyses of OMVs from C. jejuni
In order to analyze the surface structure of wild type C.
jejuni strain 81-176, we examined the bacteria by atomicBMC Microbiology 2009, 9:220 http://www.biomedcentral.com/1471-2180/9/220
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force microscopy, which revealed that there were OMVs
surrounding the bacterial cells (Figure 1A&1B). Since
recent studies [25-28] suggest that some bacterial protein
toxins are secreted in association with OMVs, we decided
to determine whether CDT could be detected in associa-
tion with such vesicles. We isolated the OMVs from cell-
free supernatants of C. jejuni after growth in biphasic
medium as described in Materials and Methods. Studies
of the OMV samples using electron microscopy revealed
that the OMVs from C. jejuni strain 81-176 were some-
what heterogeneous in size with a diameter in the range of
10-50 nm (Figure 1C). In order to visualize the protein
components of OMVs we performed SDS-PAGE analysis.
Comparison of OMV and outer membrane fraction of C.
jejuni strain 81-176 showed that there was clear similarity
of the major protein bands and most of the minor bands
(Figure 2) The N-terminal amino acid sequence of the
major protein band was determined. The result (N-termi-
nal: AS/GKEIIFS) corresponding to the most abundant
band at 45 kDa identified it as a major outer membrane
protein (MOMP CJJ81176_1275). The presence of
MOMP verified that the isolated OMVs fraction was
derived from the outer membrane compartment of the
bacteria. Another rather abundant protein in the OMVs
fraction was found to correspond to the Hsp60 (heat
shock protein 60 CJJ81176_1234). The C. jejuni Hsp60
protein is similar to, and may be regarded as a paralog to,
GroEL proteins of E. coli and many other bacteria. Gener-
ally the GroEL heat shock protein is described as a cyto-
plasmic protein. However, there is increasing evidence of
cell surface localization of GroEL from studies of different
bacterial species, e.g. in the case of H. pylori, S. typhimu-
rium, and Hemophilus influenzae [18,42,43].
Detection of CDT proteins in association with OMVs
In order to determine whether all or a subset of the pro-
teins constituting CDT were present in the OMVs, Western
immunoblot analyses with anti-CdtA, anti-CdtB, and
anti-CdtC polyclonal antisera were performed. A cdtA::km
derivative (DS104) was used as a negative control. The
insertion of the kanamycin resistance determinant has
been shown to be polar on the other genes [20] in the
cdtABC  operon and none of the CDT proteins were
detected in the cdtA::km mutant (Figure 3A-C, lanes 5-8).
OMV preparations from the wild type strain were indeed
associated with the CdtA, CdtB, and CdtC proteins as
determined by the immunoblot analyses. The protein
loading in the SDS-PAGE gel was normalized such that a
total of 3 g protein was loaded in each well. As shown in
Figure 3A-C (Lane 4), all subunits could be detected in
association with OMVs from the wild type bacteria. In
order to rule out contamination from the cytoplasmic
fraction of the bacterial cells, the OMV samples were ana-
lyzed using antiserum against the cAMP receptor protein
(CRP) as a cytoplasmic marker. There was no reactive
band detected with anti-CRP antiserum when superna-
tants and OMVs were tested (data not shown). Using an
antiserum raised against the outer membrane protein
Omp50 we further confirmed that the OMV fraction was
derived from the outer membrane compartment of the
bacteria (Figure 3D). The OMVs were also studied with
regard to lipooligosaccharide (LOS) patterns using SDS-
PAGE and silver staining of preparations treated with Pro-
teinase K. The LOS was detected in the OMV samples and
the pattern was identical to that of the whole cell samples
Surface structure analyses of C. jejuni Figure 1
Surface structure analyses of C. jejuni. Atomic force 
micrographs of (A) a C. jejuni strain 81-176 cell (Bar: 1 m) 
and of (B) small and large OMVs (examples indicated by 
arrows) on the surface of a C. jeuni cell (Bar: 100 nm). (C) 
Electron micrograph of OMVs (examples indicated by 
arrows) isolated from C. jejuni strain 81-176 (Bar: 100 nm).
Protein profile of C. jejuni outer membrane and OMVs Figure 2
Protein profile of C. jejuni outer membrane and 
OMVs. Comparison of protein composition between the 
outer membrane protein fraction (OMP) and the OMVs sam-
ple from wild type C. jejuni strain 81-176. Protein bands were 
visualized by Coomassie blue staining of a SDS-PAGE gel.BMC Microbiology 2009, 9:220 http://www.biomedcentral.com/1471-2180/9/220
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(data not shown). The relative intensity of the major
bands indicated that the LOS in the OMVs represented ca
0.2-0.5% of the total LOS of whole bacterial cells.
Immunoelectron microscopic analysis of proteis in OMVs
To more directly monitor the association of CDT proteins
with OMVs, we performed immunoelectron microscopic
analyses. By immunolocalization using anti-CdtA, anti-
CdtB, and anti-CdtC antibodies in the immunogold labe-
ling method we detected the deposition of gold particles
on the vesicles obtained from CDT-producing bacteria
(Figure 4A-C), whereas there was no labeling of OMVs
from the CDT-negative strain (Figure 4D-F). We observed
that some CDT containing vesicles were ruptured when
the OMVs samples were mixed with antiserum in the
immunogold experiment. The gold particles were mainly
observed on the material of the ruptured vesicles. It
appeared that due to the rupture of the OMVs some of the
released CDT subunits were accessible to the antiserum.
The results strongly support the suggestion that the CDT
proteins were indeed associated with OMVs of C. jejuni
strain 81-176 and it appeared that the proteins might be
internal or integral to the vesicle membrane. Since the C.
jejuni Hsp60 protein that was somehow associated with
OMVs as detected by SDS-PAGE analysis after the ultrcen-
trifugation step we also performed the immnunogold
labelling and electron microscopic examination using an
Hsp60 recognizing polyclonal antiserum raised against
the E. coli GroEL protein (Sigma-Aldrish). As shown in
Figure 5B the gold particles labelled with anti-Hsp60
antiserum were observed not in direct association with
OMVs but gold particles were associated with some amor-
phous material outside the OMVs. A similar immunogold
labelling and analysis of the OMVs preparation with anti-
Omp50 antiserum was shown in Figure 5C. In this case
the gold particles were found to be localized in direct asso-
ciation with the OMVs as expected for an outer membrane
protein. The results from these analyses indicated that the
Hsp60 protein of C. jejuni was not directly in association
with OMVs. We suggest that the presence of GroEL in the
Immunoblot detection of intra- and extra-cellular CDT of C.  jejuni Figure 3
Immunoblot detection of intra- and extra-cellular 
CDT of C. jejuni. Immunoblot analyses of samples from C. 
jejuni wild type strains 81-176 (lanes 1-4) and the cdtA::km 
mutant (lanes 5-8). Samples: 1&5; whole cells (WC), 2&6; 
supernatants 1 (S1), 3&7; supernatants 2(S2), 4&8; OMVs, 
(A) Immunoblot detection with anti-CdtA polyclonal antise-
rum, (B) immunodetection with anti-CdtB polyclonal antise-
rum. (C) immunoblot detection with anti-CdtC polyclonal 
antiserum. (D) immunoblot detection with anti-Omp50 poly-
clonal antiserum.
Electron microscopy and immunogold labelling of CDT Figure 4
Electron microscopy and immunogold labelling of 
CDT. Immunoelectron microscopic analyses of OMVs from 
wild type C. jejuni strain. 81-176 (A-C) and the cdtA::km 
mutant (D-F) using anti-CdtA (A, D), anti-CdtB (B, E), and 
anti-CdtC antisera (C, F). Arrows show the gold particles 
associated with OMVs. The square in the upper right corners 
show enlargements of parts of the micrographs. Bars corre-
spond to 100 nm.
Electron microscopy and immunogold labelling of Hsp and  Omp50 Figure 5
Electron microscopy and immunogold labelling of 
Hsp and Omp50. Immunoelectron microscopic analyses of 
OMVs. (A) OMVs of wild type C. jejuni strain 81-176 without 
antiserum (control). (B), immunolabelling with anti-Hsp 
antiserum. (C) immunolabelling with anti-Omp50 antiserum. 
White arrows show the GroEL like particles (in A) and the 
localization of gold particles on the GroEL like particles (in 
B). Black arrows show the OMVs (in A&B). Bars correspond 
to 100 nm.BMC Microbiology 2009, 9:220 http://www.biomedcentral.com/1471-2180/9/220
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OMVs preparation might be due merely to the co-precipi-
tation during the vesicle isolation procedure.
Sub-cellular localization of CDT proteins in C. jejuni cells
The presence of CDT in OMVs would imply that the pro-
teins should be localized, at least transiently, in the outer
membrane and/or periplasmic compartments of the bac-
terial cells. We also analyzed the localization of the CDT
toxin subunits in different sub-cellular (cytosolic, inner
membrane, periplasm, outer membrane) fractions of the
bacteria. The results from SDS-PAGE with silver staining
(here also serving as a control for protein loading) and
immunoblot analysis are shown in Figure 6A&6B, respec-
tively. Antisera directed against the cytosolic marker CRP
and the periplasmic protein HtrA was used to further ver-
ify the fractionation. All CDT subunits could be detected
in the whole cell lysate and in the cytoplasmic fraction
(Figure 6B). Some amount of CdtA protein was detected
in the membrane factions as well whereas very little of the
CtdB and CdtC proteins were detected in those fractions.
However, clearly detectable amounts of all CDT proteins
were found in the periplasmic fraction (Figure 6B, lane 4).
From the relative intensities of the bands detected we
could estimate the amount of each Cdt subunit protein in
the periplasmic compartment in comparison with that of
the cytoplasm. In case of CdtA we estimated that about
50% of the protein appeared in the periplasm whereas
only about 5% were detected in the membrane fractions
(Figure 6B). The CdtB and CdtC proteins were also
present at appreciable levels in the periplasm (about 20%
to 30%) in comparison with the levels in the cytoplasm.
From this data, we suggest that substantial amounts of the
CDT proteins were translocated into the periplasm of the
bacterial cells and from there may be included in the
OMVs that are being released from the bacterial cell sur-
face.
The CDT proteins might be enclosed in the OMVs
In order to further assess the nature of the association
between CDT proteins and OMVs, we performed a disso-
ciation assay as described in Materials and Methods. As
shown in Figure 7A the CDT protein was recovered with
OMVs in the pellet after treatment with NaCl, Na2CO3,
Urea, or HEPES buffer pH 7.3. Upon SDS solubilization of
the OMVs, however, the CDT proteins could not be
detected in the pellet but instead the proteins were
released and remained in the supernatant after the subse-
quent centrifugation (Figure 7A, lanes 4 & 9). These
results suggested that CDT was intimately associated with
the OMVs. Resistance to high concentration urea (8 M)
and liberation after SDS solubilization indicated that the
proteins were not merely present as protein aggregates,
but were surrounded by a membrane. To verify whether or
not the Hsp60 protein was directly associated with OMVs,
we monitored its fate in the dissociation assay using the
same procedure as was done for CDT proteins. As shown
in Figure 7B, the Hsp60 protein was partially released into
the supernatant after treatment with Na2CO3 and SDS but
not with Urea. However, most of Hsp60 remained in the
pellet even after SDS treatment (Figure 7B, lane 4). Per-
haps the formation of protein aggregates after detergent
treatment caused Hsp60 to be retained in the pellet. Nev-
ertheless, our results show that CDT and Hsp60 were not
associated with OMVs in a similar manner as judged by
these assays and the immunoelectron microscopy analy-
sis.
Analyses of CDT localization in subcellular C. jejuni fractions Figure 6
Analyses of CDT localization in subcellular C. jejuni 
fractions. Subcellular localization of CDT subunits in C. 
jejuni strain 81-176. (A), SDS-PAGE gel after silver staining 
and (B), immunoblot analyses of cell fractions from C. jejuni 
wild type strain 81-176 (lanes 1-5) and the cdtA::km mutant 
(lanes 6-10). Lanes 1&6, whole cell lysates; Lanes 2&7, cyto-
plasmic fractions 3 & 8, inner membrane fractions; Lanes 4 & 
9, periplasmic fractions; Lanes 5 & 10, outer membrane frac-
tions. Antisera for detection of CdtA, CdtB, CdtC, CRP, and 
HtrA, respectively, were used for the immunoblot analyses 
and representative results of repeated experiments are 
shown. Molecular weight markers are shown in the lane 
(MW) on the left. See materials and methods for details 
about the relative amount of the extracts used.BMC Microbiology 2009, 9:220 http://www.biomedcentral.com/1471-2180/9/220
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We have also analyzed whether the CDT protein subunits
are associated with OMVs in other C. jejuni strains. Tests
with OMVs samples from the C. jejuni strain 81116 by
immunoblot analyses using anti-CdtA, anti-CdtB, and
anti-CdtC antisera showed clearly that all CDT subunits
were associated with OMVs (data not shown). We suggest
that the vesicle associated release of CDT proteins is a
common feature among C. jejuni strains. In this context it
is also relevant to mention that a recent proteomic study
showed the CDT protein was found to be associated with
OMVs derived from the pathogenic E. coli strain IHE3034
[44].
OMV-associated CDT is biologically active
CDTs constitute a family of genetically related bacterial
protein toxins able to stop the proliferation of many dif-
ferent cultured cell lines. The primary effect of the CDTs,
regardless of their bacterial origin, is eukaryotic cell cycle
arrest at the G2/M stage with resultant cessation of cell
division [17]. Since we could detect all CdtA, CdtB, and
CdtC subunits in vesicle samples from C. jejuni strain 81-
176, we decided to test whether the CDT complex was
active in such preparations. Earlier studies described that
a purified CdtB on its own had no effect on HeLa cells, but
when it was combined with CdtA and CdtC the HeLa cells
showed cell cycle arrest in the G2/M phase [45]. Results
from other studies also indicate that CdtB internalization
is necessary for toxicity [46]. In their study, they demon-
strated that purified CdtB converts supercoiled plasmid
DNA to relaxed and linear forms and promotes cell cycle
arrest when combined with an E. coli extract containing
CdtA and CdtC whereas CdtB alone had no effect on HeLa
cells. However introduction of the CdtB polypeptide into
HeLa cells by electroporation resulted in cellular disten-
sion, chromatin fragmentation, and cell cycle arrest, all of
which are consequences of CDT action [46]. In the present
study we used a human ileocecum carcinoma cell line
(HCT8) instead of the HeLa cell line. We considered that
for the analysis of C. jejuni infection, a cell line represent-
ing the intestinal epithelium might be more relevant. In
order to analyze how cultured HCT8 cells were affected by
OMVs containing CDT, the cells were treated with the ves-
icle samples obtained from the C. jejuni wild type strain
81-176 and from the cdtA mutant strain DS104 (Figure
8A). The CDT-containing vesicle preparations from strain
81-176 induced a distinct enlargement of the HCT8 cells
(Figure 8A, panel C&D) that was not observed in case of
vesicles from the cdtA::km mutant (Figure 8A, panel E&F).
As a means to quantify the effect of the OMVs on cell cycle
arrest we measured the incorporation of [3H]-labeled thy-
midine by the HCT8 cells that had been treated with
OMVs. The thymidine incorporation data clearly indi-
cated that OMVs with CDT caused cell cycle arrest and the
level of incorporation was reduced to ca 20% when mon-
itored after 48 h of incubation (Figure 8B).
Taken together, the results in this study demonstrate that
biologically active CDT of C. jejuni is secreted from the
bacteria in association with OMVs. Furthermore, the asso-
ciation of CDT with OMVs was found to be rather tight
and we must consider that OMV-mediated release could
be a mechanism for delivery of CDT to the surrounding
environment and may be involved in the pathogenesis of
Campylobacter infections.
The present findings are reminiscent of the observations
made in case of some toxins and their tight association
with OMVs from extra-intestinal pathogenic E. coli
(ExPEC) but quantitatively there may be noteworthy dif-
ferences [27,28]. Quantification of the pore forming toxin
HlyA, that was secreted and appearing in OMVs from dif-
ferent ExPEC isolates, indicated that it represented a frac-
tion in the range between ca 2%-30%, i.e. only a sub-
fraction of the exported toxin [28]. Compared with these
other cases of toxins exported via OMVs, the present find-
Analyses of CDT dissociation from OMVs Figure 7
Analyses of CDT dissociation from OMVs. (A) Dissoci-
ation assays of CDT proteins associated with OMVs from C. 
jejuni. Samples of vesicles in 50 mM HEPES were treated for 
60 min on ice in the presence of: NaCl (1 M), Na2CO3 (0.1 
M), urea (8 M) or SDS 1%, respectively. The samples were 
then centrifuged and the resulting pellets (lanes 1-5) and 
supernatants (lanes 6-10) were analysed by SDS-PAGE and 
immunoblot analyses with anti-CdtA, anti-CdtB, and anti-
CdtC antisera. (B) Dissociation assays of Hsp60 protein. 
Samples were treated as in (A), and the immunoblot analysis 
was done with anti-Hsp60 antiserum.BMC Microbiology 2009, 9:220 http://www.biomedcentral.com/1471-2180/9/220
Page 9 of 10
(page number not for citation purposes)
ings are remarkable in that virtually all of the CDT pro-
teins released from the C. jejuni cells were found to be
OMV-associated
Conclusion
All CDT subunits from C. jejuni were released from the
bacterial cells in association with OMVs. The OMV associ-
ated toxin caused the cytolethal distending effects on tis-
sue culture cells. Our results strongly suggest that the
release of OMV associated CDT is functioning as a route
of C. jejuni to deliver all the subunits of CDT toxin (CdtA,
CdtB, and CdtC) to the surrounding environment, includ-
ing infected host tissue.
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